Morgan Stanley: Raises CRRC Corporation (01766) target price to HK$5.6, maintains "Underweight" rating
The bank rolled its valuation forward to 2027 and kept the target P/E ratio unchanged at 8x. It appreciates the company's defensive nature but believes its growth outlook is lackluster and its valuation appears insufficiently attractive.
Morgan Stanley issued a research report stating that based on CRRC Corporation's (01766) first nine months results, it has raised the target price from HK$5 to HK$5.6, maintaining an "Underweight" rating.
The bank slightly lowered the company's 2026 revenue forecast by 1%, but due to a more stable growth outlook, raised its 2027 revenue forecast by 1%; for net profit forecasts, it lowered 2026 by 3% and kept 2027 roughly unchanged.
The bank rolled its valuation forward to 2027 and kept the target P/E ratio unchanged at 8x, appreciating the company's defensiveness, but given the flat growth prospects, the valuation appears insufficiently attractive.
Related Articles

FMR LLC reduces its holdings in SUN HING VISION (00125) by 56,000 shares at approximately HK$0.28 per share.

Advanced Micro-Fabrication Equipment Inc. China (688012.SH) plans to repurchase company shares for RMB400 million to RMB500 million.

AIRDOC-B (02251) repurchased 16,300 shares on November 5 for approximately HK$148,200.
FMR LLC reduces its holdings in SUN HING VISION (00125) by 56,000 shares at approximately HK$0.28 per share.

Advanced Micro-Fabrication Equipment Inc. China (688012.SH) plans to repurchase company shares for RMB400 million to RMB500 million.

AIRDOC-B (02251) repurchased 16,300 shares on November 5 for approximately HK$148,200.






